chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she presented reaction in eyes and skin; she presented reaction in eyes and skin; twitching in the hands; pain, numbness and tingling in arms and legs; numbness and tingling in arms and legs; numbness and tingling in arms and legs; This is a spontaneous report received from a non-contactable reporter (Other HCP) from medical information team. The reporter is the patient.  A 40 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SKIN REACTION (non-serious), EYE PAIN (non-serious), outcome "unknown" and all described as "she presented reaction in eyes and skin"; MUSCLE TWITCHING (non-serious), outcome "unknown", described as "twitching in the hands"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "pain, numbness and tingling in arms and legs"; PARAESTHESIA (non-serious), HYPOAESTHESIA (non-serious), outcome "unknown" and all described as "numbness and tingling in arms and legs".  Additional information: Caller reported that she had got 1st and 2nd dose of the vaccine already but that she presented reaction in eyes and skin, twitching in the hands; pain, numbness and tingling in arms and legs; and also mentioned that she is afraid that pain presents with booster and doesn't go away. Caller asked if it is safe to take the booster since she had presented this reactions before.  The lot number for bnt162b2 was not provided and will be requested during follow up.
aware of 6 cases of Bell's Palsy by the companies making these vaccines; This is a spontaneous report from a contactable Other HCP. This Other HCP reported similar events for 6 patients. This is 1st of 6 reports.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The reporter reported since the use of modified RNA in covid vaccines,he/she had aware of 6 cases of Bell's Palsy by the companies making these vaccines since an unknown date. The event outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Bell's Palsy is not uncommon in general population. The information provided in this case is limited and does not allow a full medically meaningful assessment. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021009409 Different patient, same drug/event.;US-PFIZER INC-2021009412 Different patient, same drug/event.;US-PFIZER INC-2021009410 Different patient, same drug/event.;US-PFIZER INC-2021009411 Different patient, same drug/event.;US-PFIZER INC-2021009408 Different patient, same drug/event.
Notices dime sized, hard lump at injection site.  Now bump is at 10cm.  Patient complains of pain at injection site and it feels hot.  88 MDG physician diagnosed as cellulitis.
Lupus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (He mentioned that he took the first and second shots of the COVID-19 vaccine and has health problems; he has lupus), for COVID-19 Immunization, reaction(s): "Lupus".  The following information was reported: SYSTEMIC LUPUS ERYTHEMATOSUS (medically significant), outcome "unknown", described as "Lupus".  Clinical course: The caller was tried to schedule an in-home booster shot from Pfizer for him and for his fiancé. He mentioned that he took the first and second shots of the COVID-19 vaccine and has health problems; he has lupus. No, medical inquiry was not forwarded.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300006935 same patient, same event, different dose of vaccine;
pt recvd vax;slept all day 10am-4pm;mom claims could not be awakened easily; no fever; was fussy p/wards, same behaviour  p/ HBV #1 at birth;
Pt with h/o of multiple environmental allergies plus latex. Received vaccine at 1115am and reported itching eyes and itching ears at 1129am. She was escorted via wheelchair to the ED for f/u treatment.
At an unspecified time, the pt was vaccinated with Lymerix. Sometime thereafter, she experienced an arthritic condition. The information received on 8/10/00 provided no additional details. Additional information has been requested.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 30-JUN-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # M004116, expiration date 12-OCT-2017 (dose and route of administration were not reported) in the immunization series. There was no adverse effects reported. Administered dose of vaccine, in the worst case, experienced the temperature excursion of 31.1 degrees Fahrenheit for 8 days 3 hours 15 minutes (cumulative excursion). Data logger was involved. Additional information has been requested.
Information has been received from a registered nurse and a physician concerning an approximately 9 week old male patient who on 17-JUN-2010 (also reported as 16-JUN-2010), was vaccinated with the first PO dose of ROTATEQ. On 23-JUN-2010, the patient was inadvertently received a second partial dose of ROTATEQ. The partial dose consisted of 2 drops of ROTATEQ. No vomiting, diarrhea, or fever noted. No adverse symptoms were reported. The patient did not seek medical attention. Follow up information was received from the registered nurse and the doctor of osteopathy. The registered nurse reported that on 23-JUN-2010 at 13:00, the patient received the second PO dose of ROTATEQ (lot # 665343/1507Y). Full dose was not given. No side effect was noticed. It reported that the patient was recovered on 23-JUN-2010. Additional information is not expected.
Headache, SkinRash, Rash, NauseaVomiting, HIVES,CHILLS Narrative: Allergic to Sulfa- break out in hives. Pt. went to primary doctor jan. 14. Pt was given steroid cream for the hives, oral steroid 7 day treatment, Benadryl prn for itching. Day 6: Still currently experiencing hives and itching
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On an unknown date the patient was vaccinated with M-M-R II for prophylaxis. On an unknown date the patient experienced rubella antibody negative. The outcome of rubella antibody negative is unknown.
AROUND THE INJECTION SITE WAS A RED, RAISED, RASHY AREA. IT WAS MILDLY PAINFUL. IT MEASURED APPROXIMATELY 1" X 2". THE NEXT DAY IT BEGAN TO ITCH.
Patient stated that his face broke out in a blister like rash within 24 hours of receiving the vaccines.   After speaking with him 2.5 months later, the blisters are still scabbed over on his face.
Chills (just a couple of times), fatigue for several days, bodyaches on and off for several days ,pain in arm at injection site for 2-3 days, some joint pain  Ibuprofen every 4-8 hours, 400mg
Patient presented  8/3 in the afternoon with a complaint of soreness/tenderness near the injection site and redness several inches below the injection site.  Patient self treated soreness with OTC pain relievers. 8/4 patient state tenderness and redness improved and mostly resolved. Fully resolved by 8/6 per patient report.
After I received the vaccination within a couple of days I began to have migraine headaches. I consulted with my physician and was prescribed Verapamil for the symptoms.
PATIENT STATED SHE FELT SEDATED THE DAY AFTER THE VACCINE.
started with fever day after vaccine, next day arm started to turn red, 9/12/09 went to ER admitted for right arm cellulitis 10/21/09 Hospital records received for dates 9/13/09 to 9/15/09. DC DX: cellulites right upper arm, fever, URI. Presenting SX: Pt. received vaccinations and parent states within 12 hrs pt. had redness/pain at site, fever, vomiting x2, parent notes leg twitching. Pt parent stated at time of vaccine pt. (+)runny nose. Pt. seen in ER presenting with same sx. and inconsolable. Assessment: mild distress, erythema and induration at injection site RUA, hard, warm to touch. Right axillary nodes palpable, lethargic, bilateral wheezing, rhinorrhea, Pt. admitted, tx provided, stable at discharge. ICD9 codes: 478.19, 279.8, 682.9
Received 12 month immunization 10/9/02. Last night around 9PM, patient's left thigh became really swollen/red/hot to touch. Patient's mother stated where the Prevnar was given.
Had a mild fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Had a mild fever) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Had a mild fever). At the time of the report, PYREXIA (Had a mild fever) outcome was unknown.            No concomitant medications was provided.  No treatment medications was provided.   This case was linked to MOD-2022-512787 (Patient Link).
Tested positive for COVID on 15Nov2021 based on a test taken on 14Nov2021; Tested positive for COVID on 15Nov2021 based on a test taken on 14Nov2021; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient).   A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EP 6955), intramuscular, administered in Arm Right on 26Mar2021 as dose 2, single and received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL 3247) intramuscular, administered in Arm Right on 05Mar2021 as dose 1, single for both covid-19 immunisation (age at the time of vaccination was 55 years). The patient medical history and concomitant medications were not reported. The patient had no known allergies. No other vaccine was received in four weeks. The patient did not have covid prior vaccination. On 13Nov2021, the patient experienced tested positive for covid on 15Nov2021 based on a test taken on 14nov2021. On 14Nov2021, the patient underwent lab tests and procedures which included sars-cov-2 rna: positive (Nasal swab, Sars-cov-2 rna, ql naat, rtpcr/tma). No treatment was received for AE. Reportedly, the AE resulted in Doctor or other healthcare professional office/clinic visit. The patient was tested for covid post vaccination. The outcome of the events was reported to be recovering.    Follow-up attempts are completed. No further information is expected.
Discharge Provider: MD Primary Care Provider: PA Admission Date: 5/5/2022 Discharge Date: May 10, 2022  PRESENTING PROBLEM: Dehydration [E86.0] Failure to thrive in adult [R62.7] Bicytopenia [D75.89] Hepatic cirrhosis, unspecified hepatic cirrhosis type, unspecified whether ascites present [K74.60] COVID-19 [U07.1]   HOSPITAL COURSE:  This is a 55-year-old male with a history of chronic alcohol abuse who presented to the emergency room with a 5 day history of weakness and malaise.  He was found to have COVID-19 without respiratory component, liver failure with a bilirubin of 5.9, hypo magnesemia, hypokalemia, anemia with a hemoglobin of 7.9 right lower lobe pneumonia, urinary tract infection with findings of Enterococcus in the on urine culture, and an elevated ammonia level of 57. Abdominal imaging demonstrated large volume ascites and he had an ultrasound-guided paracentesis prior to discharge of 1.9 L. he did not demonstrate alcohol withdrawal throughout his hospitalization but was monitored for that possibility.  He was substantially improved by discharge was felt to be stable to discharge to home.
Shingles; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient is going to have an appointment for the second shot of COVID-19 vaccine on 07Feb2021. Now in the meantime, the patient come down with shingles on unspecified date and was wondering if the patient can make the appointment to have the second shot.  Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Patient came to pharmacy for a COVID vaccine and the staff asked him for his COVID vaccine card. He did not have one and was therefore asked if this was his first dose of COVID vaccine - he said yes. Pharmacist checked and there was no record of COVID vaccination. Pharmacist also checked electronic record system and there was no record of COVID vaccination. The pharmacist then explained to patient that since this was his first dose, he would come back in about a month for a second dose. Patient voiced understanding. The pharmacist administered the vaccine (monovalent COVID vaccine 0.5 ml NDC 80777-0273-10). After patient left, it was brought to the pharmacist's attention that patient was found under a partial last name and was due for the bivalent booster, not the primary series. The record did not translate over to or because of the last name difference. Nurse spoke with patient regarding incident.
Approximately 1 month after receiving the 1st dose of the Pfizer Covid-19 vaccination, my blood glucose level rose & my thyroid TSH level spiked. Approximately 5 months after receiving both doses of the Pfizer Covid-19 vaccination, my hair started falling out.  As of this date, I continue to have hair loss and tender scalp.   My thyroid TSH level did spike in my past, but is not high enough to cause hair fall per my endocrinologist.  I have never had hair loss in my past even when my TSH level spiked.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 19-AUG-2017 the patient was vaccinated with improperly stored dose of VARIVAX lot # N009767, .5 ml, subcutaneous for prophylaxis. Concomitant therapies included sterile diluent (STERILE DILUENT). No adverse effects were reported. Additional information is not expected.
I noticed the joints in all of my fingers hurt. I had an appointment with my doctor for unrelated osteoarthritis in one of my feet and I mentioned my finger joint pain. She referred me to a rheumatologist. 12/09/2021 I saw the rheumatologist and she did some blood work and x-rays, but everything came back normal. The pain subsided after a couple weeks.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter.  No treatment information was provided by reporter.
Some fatigue and arm pain the day after the vaccine. Starting 1/17/21 she had intermittent burning in her scalp. The following day she also started having a weird taste in her mouth. These symptoms continued and a few days after she also started having intermittent numbness and tingling in her face. The face parasthesias stopped on 1/23 or 1/24. The weird taste in her mouth is still intermittent but less frequent. The scalp irritation has mostly resolved.
Patient got first COVID vaccine at 9:49 AM.  Pt. started having syncope reaction two to three minutes after getting the injection. Pt was found in a chair on the floor, at 9:52.  Pt, was found COAx3 and had a patent and self-maintained airway.  Pt. was transferred to the back via a wheelchair where she laid down.  Vitals were obtained with a HR of 83 BP of 115/74, RR of 14.  Pt stated that she felt fine after laying down. Pt, waited in the back for fifteen minutes where her vitals remained stable.  After fifteen minutes Pt, walked without any obvious difficulties to observation one where she waited for another 15 minutes. Pt went home after fifteen minutes in observation one and walked out without any further incident and without any obvious difficulties.
Heat and swelling in left deltoid with possible surface blistering in an approx 5 cm area around injection site, this blistering occured on day 2 after injection.  Patient is an obese 5 yr old and after injection some vaccine oozed to surface of arm.  Pt recieved DTaP to left Deltoid where reaction occured.
Seizure-like incident while at a restaurant. Eyes rolled back in to my head, according to my friend who was with me. My vision got blurry, I started feeling nauseous, shivers, cold sweats, body felt shaky, and at first I thought I had been drugged. This "attack" lasted for a couple of minutes. After being able to get home I was in bed until 4 pm the next day. At first I had several hours where I was freezing despite being in bed fully dressed with the heat blasting, the following hours, I was sweating. I had a headache, felt nauseous, and uncomfortable all day Saturday. My reaction to the vaccine was much worse than having Covid-19. Missed work due to the symptoms from getting the vaccone.
Narrative: COVID infection following COVID vaccine series 04/26 COVID swab, result: NOT detected 04/26, Pfizer, dose #1 05/24, Pfizer, dose #2 08/19 COVID swab, result: detected 08/20 pt cc: no symptoms exposure: unknown
Nausea, vomiting, low grade fever (100.0), chills, pain at vaccine site.
Within hours of receiving the vaccine I began sweating profusely, vomiting, and feeling overwhelmingly tired.  I got very ill and stayed seriously ill for close to four years.  My face was swollen and had a red rash on it that burned and stung so badly it was difficult to even concentrate.  I developed narcolepsy (confirmed at the sleep clinic) and Lichen Planus (confirmed with biopsy).  I've never been the same since.  I was (mis)diagnosed with Lupus right after getting the vaccine and getting ill.  I do have positive ANA with fairly high titre but am told I don't have Lupus.
Patient's husband was in for an injection and stated last evening his wife had a slight rash on both arms from elbows to wrist.  Was not raised nor welted nor itchy. Rash is gone now.  Patient stopped by and showed me her arms.  No other problems.  Rash present less than 20 hours.
Site: Bruising at Injection Site-Medium, Site: Swelling at Injection Site-Mild
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient received BNT162b2 (BNT162B2), on 25Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (25Jul2022) positive. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Patient received treatment of COVID-19 from 10Jul2022 to 15Jul2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial information has been received from a nurse practitioner, for GARDASIL, a pregnancy Registry product, concerning a 17 year old female with asthma who on 08-Oct-2008 was vaccinated with 0.5ml first dose of GARDASIL (lot# 660393/0067X). Concomitant therapy included Albuterol. Subsequently the patient was pregnant. Pregnancy tests were preformed and unspecified medical attention was sought. On 08-Jan-2009 and 08-Apr-2009 the patient was vaccinated with a 0.5ml second and third doses of GARDASIL (lot# 660393/0067X) respectively. On 17-Mar-2009 the patient delivered a healthy baby boy in a hospital. No adverse effects were reported. Follow up information has been received from the nurse practitioner on 19-June-2009 concerning the patient. Concomitant therapy included Ibuprofen. The patient underwent stress testing at 8 months. Normal testing. Started prenatal care at 8 months (received no prenatal care prior to 35-36 weeks)  On 17-Mar-2009 she delivered a normal, healthy male baby, weighing 7 pounds, at 40 weeks and 4 days from the LMP. The baby's length was 21 inches, head circumference was 14 inches. There was no congenital anomalies or other compilations. There were no complications during pregnancy or labor/delivery. Medication taken during pregnancy included cough medications (Nyquil), once, for cough, started in fall month of 2008. No further information is available.
Rash on chest next day on 5/22/2019 at 4pm. Cleared with benadryl. Swollen lymph nodes in groin on right side of body 5/28/2019. Same side as injection, being monitored.
I provided a Tdap vaccination for 12 year old. After vaccine administration, mother requested I add the vaccine to her paper records. Patients paper record indicated patient had already had a Tdap in 2019. System did not have this vaccination on file.
I received my first Pfiser on January 29, 23021 I received my second Pfiser on February 17, 2021 Both were administered at clinic.  Second vaccination was administered on a Wednesday.  By Friday I was in terrible pain on my left breast.  On Sunday I was admitted to hospital with a terrible infection.  The infection could not be gotten under control with antibiotics which resulted in my having my breast implant removed.  I was hospitalized for three days.  The Implant had been in since July 2020.  I had been healthy without any change in my life style, etc. until the vaccination.  Therefore, the infection appears to be a result of the vaccination.
Symptoms: c/o flushing, chills. Vitals stable. Intervention: rest, reassurance, used bathroom ? felt better.